Dilated cardiomyopathy (DCM) is a lethal inflammatory heart disease and closely connected with dysfunction of the immune system. Glycoprotein A repetitions predominant (GARP) expressed on activated CD4 + T cells with suppressive activity has been established. defective in DCM patients and GARP seems to be a better molecular definition of the regulatory phenotype. Therefore, it might be an attractive stategy to pay more attention to GARP in DCM patients.
Summary
Dilated cardiomyopathy (DCM) is a lethal inflammatory heart disease and closely connected with dysfunction of the immune system. Glycoprotein A repetitions predominant (GARP) expressed on activated CD4
+ T cells with suppressive activity has been established. This study aimed to investigate the frequency and function of circulating CD4 + CD25 + GARP + regulatory T (Treg) cells in DCM. Forty-five DCM patients and 46 controls were enrolled in this study. There was a significant increase in peripheral T helper type 1 (Th1) and Th17 number and their related cytokines [interferon-c (IFN-c), interleukin (IL-17)], and an obvious decrease in Treg number, transforming growth factor-b 1 (TGF-b 1 ) levels and the expression of forkhead box P3 (FOXP3) and GARP in patients with DCM compared with controls. In addition, the suppressive function of CD4 + CD25 + GARP + Treg cells was impaired in DCM patients upon T-cell receptor stimulation detected using CFSE dye. Lower level of TGF-b 1 and higher levels of IFN-c and IL-17 detected using ELISA were found in supernatants of the cultured CD4 + CD25 + GARP + Treg cells in DCM patients compared with controls.
Together, our results indicate that CD4 + CD25 + GARP + Treg cells are
Introduction
Dilated cardiomyopathy (DCM) is a lethal inflammatory heart disease characterized by the presence of myocardium disorder with dilatation of the ventricles, but not coronary artery disease, hypertension or valvular abnormalities. [1] [2] [3] It is generally accepted that DCM caused by viral myocarditis is associated with hepatitis C virus, Coxsackievirus B, adenoviruses and parvovirus B19. 4, 5 Previous studies have also reported the underlying pathogenic mechanisms of viral myocarditis, which can eventually lead to cardiac dysfunction. 6, 7 Although no clear mechanism of the transition from viral myocarditis to DCM has been established, there is no doubt that the regulation of immune system plays a vital role in the pathogenesis of DCM. [8] [9] [10] 
CD4
+ regulatory T (nTreg) cells are essential for maintaining immune tolerance by inhibiting the hyperactivation of effector T cells and have an indispensable role in preventing the progression of several inflammatory diseases. 8, 11 Forkhead box P3 (FOXP3), a master transcriptional regulator of nTreg cells, is specifically expressed in naturally arising CD4 + Treg cells and can be used to define the classical Treg phenotype. [12] [13] [14] However, FOXP3 as an intracellular molecular marker has hampered viable cell sorting for function assay, so discriminating Treg cells from activated T cells based on other member markers was an imminent strategy. Recently, glycoprotein A repetitions predominant (GARP), which is highly expressed on the surface of stimulated Treg clones but not on T helper (Th) clones, was identified as a new specific marker of activated human Treg cells. [15] [16] [17] It has been proved that GARP serves as a receptor for latent transforming growth factor-b (TGF-b), and can bind directly to latency-associated peptide on the surface of activated human Treg cells. 18 More notably, CD25 + T cells sorted for high GARP expression can dissect the duality of 
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Treg/T helper type 17 (Th17) cell differentiation and displayed more potent suppressive activity compared with CD25 + GARP À cells. 19, 20 Our group's previous research found that the number and suppressive function of circulating CD4 + CD25 + GARP + Treg cells were impaired in patients with acute coronary syndrome, which can result in excess effector T-cell proliferation. [21] [22] [23] We also reported that atorvastatin could improve the inflammatory response by up-regulating the expression of GARP on regulatory T cells. 24 However 
Materials and methods

Study subjects
Based on the exclusion and inclusion criteria as presented below, 45 patients with DCM (mean age AE SD = 48Á6 AE 12Á5 years, 10 female, 35 male) without detectable aetiology between June 2015 and February 2016 in the Union Hospital of Huazhong University of Science and Technology (Wuhan, China) were enrolled in this study. Diagnosis of DCM was based on clinical criteria and other diagnostic procedures according to the guidelines of the World Health Organization. Inclusion criteria for DCM were the presence of left ventricular dilatation, with left ventricular end-diastolic dimension ≥ 5Á5 cm and left ventricular ejection fraction < 40%, assessed by echocardiography. Moreover, all of them were treated with diuretics, spironolactone and angiotensin-converting enzyme inhibitor according to guidelines. Patients were excluded if any of the following were present: other autoimmune diseases, valvular disease (except relative mitral and/or tricuspid regurgitation), tumour, severe vascular lesions, serious infection recently, endocrine disease, clinically serious hepatic or renal disease, receiving immunosuppressive agents, and lack of informed consent from the patient. Normal controls were those who have no heart organic diseases, no other serious diseases (mean age AE SD = 45Á6 AE 9Á5 years, 15 female, 30 male). All patients and normal controls provided written informed consent before the study. Ethical approval for this study was granted by the ethics committee of Tongji Medical College of Huazhong University of Science and Technology and this investigation conformed to the principles outlined in the Declaration of Helsinki.
Blood samples preparation
Peripheral blood samples were obtained from all the patients by sterile venepuncture within 24 hr after admission. Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll density gradient centrifugation and then used for cell culture, flow cytometric analysis, Western blot and real-time PCR. Serum was collected after centrifugation, aliquoted, and frozen at À80°for determination of cytokine levels.
Flow cytometric analysis of Th1, Th2, Th17 and Treg Analysis of Treg cells. The PBMCs were washed twice with PBS and then resuspended at a density of 2 9 10 6 cells/ml in complete culture medium (RPMI-1640 suspended with 10% heat-inactivated fetal calf serum; Gibco BRL, Grand Island, NY).The cell suspension was seeded in 24-well culture plates. For GARP induction, cells were stimulated with soluble anti-CD3 and anti-CD28 antibodies (2 lg/ml each; eBioscience, San Diego, CA) for 24 hr. The incubator was set to 37°under a 5% CO 2 environment. For Treg analysis, PBMCs (stimulation with CD3/CD28 for 24 hr or no stimulation) were stained with anti-human CD4-FITC (R&D Systems, Minneapolis, MN), anti-human CD25-APC (R&D Systems), and anti-human GARP (PE) (eBioscience) for 30 min at 4°. Anti-mouse IgG1-PE (eBioscience) isotype controls were used to enable normalization and confirm antibody specificity. After surface staining, the cells were washed with PBS, fixed and permeabilized with fix/permeabilization reagent at 4°for 30 min, and washed twice in 1 9 permeabilization buffer and incubated with an anti-human Foxp3-PEcy5 (eBioscience) at 4°for 30 min.
Analysis of Th1, Th2 and Th17. For Th cell analysis, PBMCs were seeded at a density of 2 9 10 6 cells/well in RPMI-1640 medium with 10% heat-inactivated fetal calf serum (Gibco BRL) and stimulated with PMA (50 ng/ml; Sigma, St Louis, MO) plus ionomycin (1 lM, Sigma) and monensin (500 ng/ml, eBioscience) for 4 hr at 37°under 5% CO 2 . After stimulation, the cells were washed with PBS and then incubated with anti-human CD4-FITC (R&D Systems) antibody at 4°for 30 min, washed twice in 1 9 permeabilization-buffer and stained with antihuman interferon-c (IFN-c) PE-cy7 (eBioscience), antihuman interleukin-17 (IL-17) -PE (R&D Systems) or anti-human IL-4-PE (R&D Systems) antibody at 4°for 30 min. Anti-mouse IgG1-PE and anti-rat IgG2-PEcy7 (eBioscience) isotype controls were used to enable normalization and confirm antibody specificity. The catalogue numbers of all antibodies used in this study are listed in Table S4 .
Flow cytometric acquisition was performed using a FACSCalibur (BD Immunocytometry Systems, San Jose, CA), and all analyses were performed using FLOWJO software (FlowJo, LLC, Ashland OR97520).
Proliferation and functional suppression assays
After 24 hr of stimulation with anti-human CD3 and antihuman CD28 antibodies, PBMCs from controls (n = 6) and patients with DCM (n = 6) were stained with anti-human CD4-Peridinin chlorophyll protein-Cy5.5 (eBioscience), anti-human CD25-APC (R&D Systems), and anti-human GARP-PE (eBioscience) for 30 25 Then cells were cultured as following set-up: (i) with stimulation of anti-CD3 and anti-CD28. All the T cells were incubated in complete culture medium (RPMI-1640 supplemented with 100 U/ml penicillin and 100 lg/ml streptomycin, and with 10% heat-inactivated fetal calf serum, Gibco BRL) with a final volume of 200 ll/well in 96-well plates with or without plate-bound anti-CD3 (10 lg/ml; eBioscience) and soluble anti-CD28 (5 lg/ml; eBioscience) for 4 days. Proliferation of Tresp cells were analysed by flow cytometry based on CFSE dilution of gated CD4 + T cells. The difference in the percentages of CFSE low cells in each group and the ratio of these percentages were calculated.
Real-time PCR
Total RNA was extracted with TRIzol extraction (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions and converted into cDNA using PrimeScript RT Reagent Kit (TaKaRa, Shiga, Japan). The 10-ll PCR mixture contained 1 lg of total cDNA and 5 pmol each of the primers which were purchased from Applied Biosystems (Foster City, CA). All reactions were performed with SYBR Premix Ex TaqII (TaKaRa) and incubated in an Applied Biosystems 7500 Real-Time PCR system (BIO-RAD, Singapore) in a 96-well plate according to the manufacturer's protocol.
Primer sequences used in this study are listed in the Supplementary material (Table S2 ). For each sample, the mRNA expression level was normalized to that of GAPDH.
Western blot analysis
Total protein was isolated from cultured PBMCs and quantified using a BCA protein assay kit (Pierce Biotechnology Inc., Rockford, IL). The following primary antibodies were used: anti-rat/human GAPDH (1 : 1000 dilution; Immunoway, Plano, TX) and anti-human GARP (0Á3 lg/ml, R&D Systems). Protein samples were resolved on an 10% SDS-PAGE gel and then immunoblotted to PVDF membranes. The blots were blocked with 5% nonfat milk for 2 hr at room temperature, then probed with the specific primary antibody and incubated at 4°over-night. The membranes were washed and further incubated with secondary horseradish peroxidase-conjugated antibody (1 : 5000 dilution; Cell Signaling Technology, Danvers, MA) for 2 hr at room temperature. Finally, the Western blot bands were washed and developed with super ECL reagent (Thermo Scientific, Waltham, MA), and then they were semi-quantitatively analysed using densitometric methods in each group, with GAPDH as the internal control.
Cytokines detection
Levels of TGF-b 1 , IL-10, IFN-c and IL-17 in patient plasma and cell culture supernatant were measured by an ELISA according to the manufacturer's instructions (both from R&D Systems). The intra-assay and inter-assay variation coefficients for all ELISA were < 10%. All samples were measured in duplicate.
Statistical analysis
Values were expressed as mean AE SD in the text and figures. The Student's t-test was used to detect differences between two groups and one-way analysis of variance for multiple comparisons, followed by a post hoc StudentNewmann-Keuls test when necessary. A probable value of P < 0Á05 was considered to be statistically significant.
Results
Basic clinical characteristics
Basic clinical characteristics of the study population were summarized in Table 1 Fig. 1a-e) . Additionally, as shown in Fig. 1(f) , the mRNA expression of GARP and FOXP3 was consistent with the results of flow cytometry, showing lower in DCM patients compared with the control groups (both P < 0Á01).
Levels of TGF-b 1 and IL-10 in serum and PBMCs in two groups
We tested levels of TGF-b 1 and IL-10 in serum using ELISA in patients with DCM and the control groups. As shown in Fig. 2(a) , the level of TGF-b 1 was decreased in patients with DCM compared with the control groups (P < 0Á01), showing a positive correlation with the frequency of CD4 + CD25 + GARP + Treg cells. Contrastingly, IL-10 level was increased significantly in the DCM group compared with the control group in Fig. 2 (b) (P < 0Á05). In addition, as shown in Fig. 2(c,d) , the mRNA expression of TGF-b 1 in PBMCs showed lower and IL-10 expression showed higher in patients with DCM compared with controls. 26, 27 In addition, the frequency of CD4 + GARP + cells was decreased in patients with DCM compared with controls, and the frequency of CD4 + FOXP3 + cells was also lower in patients with DCM than that in the control group (Fig. 3a,c) (Fig. 3b,d ). Meanwhile, we found that the frequency of CD4 + CD25 + GARP + FOXP3 + Treg cells was also lower in patients with DCM than that of controls (Fig. 3b,d ), though the percentage of CD4 + CD25 + GARP + FOXP3 + cells among the CD4 + CD25 + GARP + fraction showed no significant difference between patients with DCM and control groups, as shown in Fig. 3(e) .
In the present study, we also examined both mRNA and protein expression levels of GARP on total PBMCs. As shown in Fig. 3(f,g ), both expressions of GARP mRNA and GARP protein were remarkably reduced in patients with DCM compared with control groups (P < 0Á01 and P < 0Á01). As shown in Fig. 4(b) , the frequency of Th1 (CD4 + IFNc + /CD4 + T cells) was markedly higher in patients with DCM compared with the control groups. Similarly, we observed that the frequency of Th17 (CD4 + IL-17 + /CD4 + T cells) was also higher in patients with DCM (4Á12 AE 1Á01%) compared with the control groups in Fig. 4(c) . But, the frequency of Th2 (CD4 + IL-4 + /CD4 + T cells) showed no significant difference between DCM patients and control groups, as shown in Fig. 4(d) . In addition, Th1 and Th17 mRNA expression levels from PBMCs were remarkably higher in patients with DCM compared with normal controls (both P < 0Á001), though the expression of IL-4 showed no obvious difference in the two groups (Fig. 4e) Fig. 5(b) . CD4 + CD25 + GARP + Treg cells from the patients with DCM and the control groups were both able to suppress the proliferation of Tresp cells to different extents. But CD4 + CD25 + GARP + Treg cells from the patients with DCM showed an impaired suppressive function compared with the control groups (Fig. 5c ). In addition, the suppressive potential of Treg cells had a close correlation with the ratio of Tresp : Treg cells, as increased cell ratio resulted in a decreased percentage of suppression (Fig. 5d ). In conclusion, the experimental data indicated that CD4 + CD25 + GARP + Treg cells from patients with DCM presented a compromised suppressive function.
We next assessed the levels of IFN-c and IL-17 in the co-cultured T cells. As seen in Fig. 6(a,b) , CD4 + CD25 + GARP + Treg cells from patients with DCM exhibited a reduced capacity to suppress IFN-c and IL-17 secretion compared with normal controls. We also measured the TGF-b 1 level in the supernatants of cultured CD4 + CD25 + GARP + Treg cells in two groups. As shown in Fig. 6 (c), TGF-b 1 level was reduced in the DCM group compared with the normal group. 26, 27, 34 In this study, our data showed that the frequency of CD4 + CD25 + Treg cells and the expression of FOXP3 were markedly lower in patients with DCM compared with control groups with or without T-cell recepetor stimulation, which conformed to the findings of previous studies showing that the percentage of suppressor/cytotoxic T cells was lower in patients with DCM compared with controls. 26, 35 In contrast, the frequencies of Th17 and Th1 were higher in patients with DCM compared with control groups, though the frequency of Th2 was comparable in these two groups.
Beyond that, one of the Treg-related cytokines (TGF-b 1 ) was reduced in DCM, showing a positive correlation with Treg cells. The result suggested that TGF-b 1 may play a protective role in the onset of DCM partly through acting as one of the effective factors of Treg cells. However, the level of IL-10 was increased in the serum of patients with DCM, perhaps in an effort to drive a protective reaction for terminating inflammation and heart injury. 9 In conclusion, all of the data reflected disturbed Th17/Treg and Th1/Th2 cytokine profiles during the development and progression of DCM. So identifying the precise effect and mechanism of autoimmune disorders in the development of DCM is particularly important.
Although FOXP3 is a key regulator of nTreg cells and can be used to define the classical Treg phenotype, many activated (non-regulatory) human T cells also express FOXP3, which would limit its use as a bona fide marker for human nTreg cells. 12, 36 Other surface markers, which are not only expressed in nTreg cells but also up-regulated in activated effector cells, appear to be important for the identification of the Treg phenotype. It has been reported that GARP, which is highly expressed on the surface of stimulated Treg clones but not on Th clones, is more reliable in characterizing activated Treg cells than FOXP3 in diseases with chronic immune activation, such as HIV. 19 In the current study, we found that the fre Suppressor T lymphocyte function in patients with DCM has been studied by some researchers with discrepant results, which may be caused by many uncontrollable factors. 37, 38 No matter what the findings, defining the suppressor cells for assessing cell-subset function in patients with DCM seems to be a valid solution to explore the pathogenesis of the disease. In this study, we found that human CD4 26 The discrepancy may be explained by the differences in the cultivation of the cell concentration, the purity of sorted T cells, and many uncontrollable factors. Nevertheless, our data confirmed that CD4 + CD25 + GARP + Treg cells with damaged function played an important role in patients with DCM. In addition, these data were in concert with the previous studies by Wang et al. and Probst-Kepper et al., 19, 39 GARP expression was shown to correlate with the suppressive activity of Treg cells and this suppressive activity was impaired in the absence of GARP.
Moreover, it has been demonstrated that soluble GARP under inflammatory conditions could not only promote Th17 differentiation, but also cooperate with TGF-b 1 to induce Treg cell differentiation.
40 Active TGF-b 1 is a pleiotropic cytokine that could regulate FOXP3 expression and influence the function of Treg cells by inducing SMAD2/3 phosphorylation, which acts as a positive role in the initial stages of inflammation. 41 Additionally, Veronika Nindl et al. have demonstrated that IFN-c was a major effector cytokine driving the initial inflammatory process and that the cooperation of IFN-c and IL-17A was essential for the development of the progressive disease. 5 In this study, our data indicated that CD4 + CD25 + GARP + Treg cells could secrete TGF-b 1 and inhibit the secretion of IFN-c and IL-17 and, more notably, this capacity of secretion anti-inflammatory cytokines and inhibition of pro-inflammatory cytokines was impaired in patients with DCM. For the reason of the reduced capacities of CD4 + CD25 + GARP + Treg cells, the resistance of inflammatory cytokine secretion was weakened in patients with DCM, which led to the development of pathological process and aggravation of cardiac function. 
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